Literature DB >> 200708

Characterization of two distinct molecular populations of type I mouse interferons.

W E Stewart, S LeGoff.   

Abstract

The molecular heterogeneity of acid-stable (Type I) mouse interferons induced in C243 cells by Newcastle disease virus was analysed by SDS-polyacrylamide gel electrophoresis under non-reducing and reducing conditions, and the profiles of antiviral activities obtained were characterized biologicaly in mouse cells and in heterologous (guinea-pig) cells. Two bands of activity, A and B, were consistently present in all interferon preparations tested: under reducing conditions, the activity in all fractions of band A (with a peak of activity at about 38000 daltons) was uniformly increased, while that of band B (with a peak at about 22000 daltons) was uniformly diminished. All the active fraction in band A had only slight activity (less than 10% of homologous titres) on guinea-pig cells, whereas all those in band B were significantly more active an guinea-pig cells than on homologous L cells. Thus, mouse type I interferon preparations contain two molecular populations of interferons that can be distinguished physically (by size), biochemically (by the effect of reduction on reactivation from SDS) and biologically (by activity in heterologous cells).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200708     DOI: 10.1099/0022-1317-37-2-277

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.

Authors:  W E Stewart; T Chudzio; L S Lin; M Wiranowska-Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Production, purification and characterization of rat interferon.

Authors:  L S Lin; S L Abreu
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Studies on Brucella interferon: chromatographic behaviour and purification.

Authors:  C Bousquet-Ucla; J Wietzerbin; E Falcoff
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.